Loading...
TrendSpott

TrendSpott

TrendSpott
 
 
Johnson & Johnson
168.34
-0.70%
 
Recommendation
JNJ Johnson & Johnson
  Login
 
 
Last Price
 
Change
 
168.34
 
-0.70%
 
 

 
Sentiment
 
  Login to display
 
 

177.2

170.71

161.33

172.31

 
 
1m
3m
6m
1y
 

Summary

  Login to display Johnson & Johnson (JNJ) recommendation from the last 90 days from financial news and social media.
 

Rewards

TrendSpott

 Earnings are forecast to grow

 

Technical Indicators

TrendSpott

 RSI is now oversold

TrendSpott

 Price dropped 9 days in a row

 
 

Risk Level

 
TrendSpott
 

Johnson & Johnson (JNJ) has Moderate Risk Level

Click here to check what is your level of risk

 

Analysts Opinion

Click on the category for more information
 
 
Earnings ×
 

Earnings

4.00
 
 
 
Rating ×
 

Rating

3.00
 
 
Momentum ×
 

Momentum

3.15
 

TrendSpott

Has been gaining momentum

 
Activity ×
 

Activity

3.94
 

TrendSpott

Debt capital raise

 
Potential ×
 

Potential

5.00
 

TrendSpott

Earnings are forecast to grow

 
 

Analysts Opinion

Analysts opinion is positive but there was a setback from the past 3 months

 

Street Consensus

Buy
Opinion
Trend
Score
Potential
Score
 
47%
50%
31%
100%
 
On Track
On Track
On Track
 

Street Opinion 

Street view is bullish and have positive views on the near-term outlook

 
Events Rating
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
Positive vs Negative
 
47%
5%
Positive
Negative
26 out of 55
events present
3 out of 55
events present
 

 
Events Calendar
Click for more information
 
December
S
M
T
W
T
F
S
January
S
M
T
W
T
F
S
 
Highlights
Last
Modify
Closing
Price
%
Change
 
Options Activity
This Week
169.76
-1.51%
 
Options Activity
1 Week Ago
175.58
-2.58%
 
Downgrade
1 Week Ago
180.25
+0.81%
 
Capital Raise
2 Weeks Ago
180.13
+1.07%
 
Options Activity
3 Weeks Ago
177.06
-0.35%
 
Latest Events

johnson & johnson a top ranked safe dividend stock with 2.7% yield (jnj). johnson &.; johnson (symbol: jnj) has been named to the dividend channel s.a.f.e. 25 list signifying a stock with above-average dividendrank statistics including a s

Nasdaq Symbol - ABMD

Today

Potential

noteworthy wednesday option activity: sedg dpz jnj. among the underlying components of the s&.p; 500 index we saw noteworthy options trading volume today in solaredge technologies inc (symbol: sedg) where a total of 4015 contracts have tra

Nasdaq Symbol - NRZ

Wed Jan 18, 2023

Momentum

iwd jnj xom cvx: etf outflow alert. looking today at week-over-week shares outstanding changes among the universe of etfs covered at etf channel one standout is the ishares russell 1000 value etf (symbol: iwd) where we have detected an appro

Nasdaq Symbol - BTRS

Tue Jan 17, 2023

Potential

johnson & johnson cuts production ends contracts for not so successful covid-19 shot. ) has significantly scaled back its efforts of manufacturing its covid-19 vaccine after facing a fall in demand. the fda approved the single-dose shot in february 202

Benzinga - large-cap

Fri Jan 13, 2023

Activity

j&j; slashes production of its covid-19 vaccine. after mobilizing to quickly develop and manufacture a covid-19 vaccine johnson &.; johnson has vastly scaled back its efforts in producing the shots as it faces slumping demand

The Wall Street Journal - U.S. Business

Fri Jan 13, 2023

Momentum

jnj crosses below key moving average level. in trading on wednesday shares of johnson &.; johnson (symbol: jnj) crossed below their 200 day moving average of $173.56 changing hands as low as $173.55 per share. johnson &.; johnson shares

Nasdaq - News

Wed Jan 11, 2023

Momentum

notable monday option activity: sig jnj nvax. among the underlying components of the russell 3000 index we saw noteworthy options trading volume today in signet jewelers ltd (symbol: sig) where a total of 4697 contracts have traded so far re

Nasdaq Symbol - TEN

Mon Jan 9, 2023

Momentum

johnson & johnson unusual options activity. someone with a lot of money to spend has taken a ish stance on ). and retail traders should know. we noticed this today when the big position showed up on publicly available options history that we track here

Benzinga - markets

Mon Jan 9, 2023

Momentum

fate to end janssen deal and prioritize pipeline development. fate therapeutics inc. fate announced that it has declined a proposal from janssen biotech inc. a johnson &.; johnson jnj company for the continuation of the collaboration

Nasdaq Symbol - JNJ

Fri Jan 6, 2023

Activity

fate faces slew of analyst downgrades after j&js; janssen unit ends agreement.

Seeking Alpha - All News

Fri Jan 6, 2023

Rating

j&js; consumer health unit kenvue files for United States ipo. johnson & johnsons consumer health unit kenvue on wednesday filed for a initial public offering with the United States securities and exchange commission.

Nasdaq Symbol - VRS

Wed Jan 4, 2023

Activity

johnson & johnson (jnj) gains as market dips: what you should know. johnson &.; johnson (jnj) closed at $178.19 in the latest trading session marking a 0.87% move from the prior day. this move outpaced the s&.p; 500s daily loss of

Nasdaq Symbol - JNJ

Tue Jan 3, 2023

Momentum

iwb googl jnj cvx: large inflows detected at etf. looking today at week-over-week shares outstanding changes among the universe of etfs covered at etf channel one standout is the ishares russell 1000 etf (symbol: iwb) where we have detected

Nasdaq - ETFs

Thu Dec 29, 2022

Potential

johnson & johnson: aspects to consider after acquiring abiomed.

Seeking Alpha - Latest Articles

Wed Dec 28, 2022

Activity

notable thursday option activity: jnj efc ma. looking at options trading activity among components of the russell 3000 index there is noteworthy activity today in johnson &.; johnson (symbol: jnj) where a total volume of 47863 contracts ha

Nasdaq - News

Thu Dec 22, 2022

Momentum

johnson & johnson closes abiomed acquisition.

Seeking Alpha Symbol - ABMD

Thu Dec 22, 2022

Activity

johnson & johnson (nyse:jnj): this dividend king is an appealing retirement stock.

Nasdaq - Stocks

Thu Dec 22, 2022

Activity

a look at abiomed before the $380/share buyout from johnson & johnson.

Seeking Alpha Symbol - ABMD

Wed Dec 21, 2022

Activity

notable tuesday option activity: shak zs jnj. looking at options trading activity among components of the russell 3000 index there is noteworthy activity today in shake shack inc (symbol: shak) where a total volume of 3843 contracts has been

Nasdaq - Markets

Tue Dec 13, 2022

Momentum

noteworthy etf inflows: itot googl jnj cvx. looking today at week-over-week shares outstanding changes among the universe of etfs covered at etf channel one standout is the ishares core s&.p; total United States stock market etf (symbol: i

Nasdaq - Markets

Tue Dec 13, 2022

Potential

sea uipath j&j; snack foods and other big gainers from tuesday. United States stocks closed higher on tuesday with the nasdaq composite gaining more than 150 points. here is the list of some big stocks recording gains in the previous session. ) jumped 3

Benzinga - markets

Wed Nov 16, 2022

Momentum
Rating

johnson & johnson could level up with its $16.8 billion purchase of abiomed. healthcare conglomerate johnson & johnson (nyse: jnj) recently made headlines by announcing it will acquire medical device company abiomed for $16.6 billion in an all-cash transa

Nasdaq Symbol - ABMD

Thu Nov 10, 2022

Activity

abiomed climbs 52% on $380/ share buyout deal with johnson & johnson.

Seeking Alpha Symbol - ABMD

Tue Nov 1, 2022

Activity
Momentum

abiomed to be bought by johnson & johnson in $16.6 bln deal. stock surges in pre-market. (rttnews) - drug major johnson & johnson (jnj) tuesday said it has entered into a definitive agreement to acquire abiomed inc. (abmd) a provider of cardiovascular med

Nasdaq Symbol - VTAQ

Tue Nov 1, 2022

Activity

johnson & johnson to buy abiomed in $16.6 billion deal. johnson & johnson said on tuesday it will acquire abiomed in a deal valued at $16.6 billion to boost the healthcare conglomerates medical devices business.

CNBC - Top News

Tue Nov 1, 2022

Activity

j&j; to buy abiomed in $16.6 bln deal. johnson & johnson said on tuesday it will acquire abiomed inc for a deal valued at $16.6 billion to boost the healthcare conglomerates medical devices business.

Nasdaq - News

Tue Nov 1, 2022

Activity

johnson & johnson expands medtech footprint with acquisition of abiomed.

Seeking Alpha - All News

Tue Nov 1, 2022

Activity

sonnet stock soars 16% on collaboration with j&j; for 3 drug compounds.

Seeking Alpha Symbol - JNJ

Mon Oct 31, 2022

Activity
Momentum

essa drops 26% as johnson & johnson ends trial enrollment for lead asset.

Seeking Alpha Symbol - EPIX

Mon Oct 31, 2022

Momentum

johnson & johnson breaks above 200-day moving average - ish for jnj. in trading on monday shares of johnson & johnson (symbol: jnj) crossed above their 200 day moving average of $171.87 changing hands as high as $172.08 per share. johnson & johnson s

Nasdaq Symbol - JNJ

Mon Oct 24, 2022

Momentum

 
 
 
TrendSpott

Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future

FIND US ON

TrendSpott on Twitter TrendSpott on YouTube TrendSpott on stocktwits TrendSpott Rss
 

Receive our daily JNJ alerts

Enter your email to receive daily alerts

SECURITY POWERED BY

secure
guaranteed
 
Home

Leading Gainers

Upgrades

Downgrades

Top Leaders

 
Categories

Ipo's

Dividend

Option Activity

Insiders Activity

Institutional Holdings

 
Tags

New Products

FDA Approvals

Agreements

Financial Reports

 
About Us

Log In

Sign Up

Contact Us

Terms of use

Privacy Policy

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by TrendSpott including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
TrendSpott

TrendSpott

Get the pulse of the market

 
TrendSpott

TrendSpott

JNJ Johnson & Johnson

Last Price
168.34
Change
-0.70%
Recommendation
  Login to display
 
 

Recently Viewed

 

JNJ

Johnson & Johnson

 
 
 

Most Trending

 
 
 
 
 
 
 
 

Summary

  Login to display Johnson & Johnson (JNJ) recommendation from the last 90 days from financial news and social media.

 
 
177.2
170.71
161.33
172.31
 
 
1m
3m
6m
1y
 
Sentiment
 

  Login to display

Rewards

TrendSpott

 Earnings are forecast to grow

Technical Indicators

TrendSpott

 RSI is now oversold

TrendSpott

 Price dropped 9 days in a row

 
 
 
 
Street Consensus
 
Buy
Opinion
Trend
Score
Potential
Score
 
50%
31%
100%
On Track
On Track
On Track
 
47%
5%
Positive
Negative
26 out of 55
events present
3 out of 55
events present
 

Street Opinion

Street view is bullish and have positive views on the near-term outlook

 
 
Analysts Opinion
Hover the category for more information
 
 
Earnings ×
 

Earnings

4.00
 
 
 
Rating ×
 

Rating

3.00
 
 
Momentum ×
 

Momentum

3.15
 

TrendSpott

Has been gaining momentum

 
Activity ×
 

Activity

3.94
 

TrendSpott

Debt capital raise

 
Potential ×
 

Potential

5.00
 

TrendSpott

Earnings are forecast to grow

 
 

Analysts Opinion

Analysts opinion is positive but there was a setback from the past 3 months

 
 
 
Events Rating
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
 
Events Calendar
Hover on calendar for more information
 
December
 
S
M
T
W
T
F
S
 
 
 
January
S
M
T
W
T
F
S
 
 
 
 
Highlights
Last
Modify
Closing
Price
%
Change
 
Options Activity
This Week
169.76
-1.51%
 
Options Activity
1 Week Ago
175.58
-2.58%
 
Downgrade
1 Week Ago
180.25
+0.81%
 
Capital Raise
2 Weeks Ago
180.13
+1.07%
 
Options Activity
3 Weeks Ago
177.06
-0.35%
 
 
 
TrendSpott

Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future

FIND US ON

TrendSpott on Twitter TrendSpott on YouTube TrendSpott on stocktwits TrendSpott Rss

 

Receive our daily JNJ Alerts

Enter your email to receive daily alerts

 

SECURITY POWERED BY

TrendSpott
TrendSpott
 
Home

Leading Gainers

Upgrades

Downgrades

Top Leaders

Categories

Ipo's

Dividend

Option Activity

Insiders Activity

Institutional Holdings

Tags

New Products

FDA Approvals

Agreements

Financial Reports

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by TrendSpott including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
 
 
 

Top Headlines